SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB
http://www.w3.org/2000/01/rdf-schema#comment
"The performance-enhancing effect of recombinant erythropoietin treatment is greater than the duration and diagnosis of hematologic changes associated with recombinant erythropoietin misuse."
xsd:string
http://purl.uniprot.org/uniprot/#_DFB33D811AEC4284D1D5BC0253BB088DE723E853D51602012E5843321B0B1694F6F8550244AC11D488BBA68009D72B02
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB
http://purl.uniprot.org/uniprot/P01588
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB
http://purl.uniprot.org/uniprot/#_P01588-mappedCitation-15339684
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C2B9CBD48B235D9939E9E67C7EB8B7FF0809CF388574283D9922F5ABD8BE649522A5A74C6DF15F937CECEBF4B15525DB